Impaired IgG antibody production to pneumococcal polysaccharides in patients with ataxia-telangiectasia
- PMID: 10535610
- DOI: 10.1023/a:1020599810261
Impaired IgG antibody production to pneumococcal polysaccharides in patients with ataxia-telangiectasia
Abstract
Various factors seem to be etiologic in the susceptibility to sinopulmonary infections in ataxia-telangiectasia (A-T) patients, i.e., low serum and salivary IgA, low serum IgG2, and even aspiration of saliva. S. pneumoniae is a common pathogen responsible from pulmonary infections and impaired antibody response to polysaccharide antigens is seen in patients with IgG2 and IgA deficiency as well as patients with CVID and WAS. We studied IgG-type antibody production to six pneumococcal serotypes in 29 A-T patients by ELISA before and 3-4 weeks after pneumococcal vaccine. The response was considered positive when the antibody titer was >10 U/ml but weak when the titer was 10-20 U/ml. Twenty-two of 29 (76%) patients did not respond to any of the serotypes, 5 (17%) showed a positive response to one serotype, 1 (3.4%) to two serotypes, and 1 (3.4%) to four serotypes. With conversion to gravimetric units (ng IgG/ml) and >1800 ng/ml (300 ng Ab N/ml) considered a positive response, 5 of 29 (17.2%) patients showed a positive response (300 ng ab N/ml) to two or fewer serotypes. All patients tested produced IgG antibody to tetanus toxoid. Sixteen of 27 (59.3%) patients had low IgG2 and four (14.8%) had low IgG3 levels, while 18 (62.1%) of 29 patients had low serum IgA. No correlation was found either between serum Ig isotype levels and antipolysaccharide antibody response or between susceptibility to infection and antibody production. The mechanism responsible for disturbed antipolysaccharide (TI-2 antigen) antibody production in patients with A-T needs to be investigated. It may provide additional information on the function of the ATM gene product and be helpful in clarifying the role of B cells and contribution of T cells in TI-2 responses.
Similar articles
-
Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections.Ann Allergy Asthma Immunol. 1996 Apr;76(4):341-6. doi: 10.1016/S1081-1206(10)60035-X. Ann Allergy Asthma Immunol. 1996. PMID: 8612116
-
Time course of antibody response to tetanus toxoid and pneumococcal capsular polysaccharides in patients infected with HIV.J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 15;19(5):471-7. doi: 10.1097/00042560-199812150-00005. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9859960
-
Pneumococcal antibody response in children with recurrent respiratory tract infections: A descriptive study.Arch Pediatr. 2024 Jul;31(5):293-298. doi: 10.1016/j.arcped.2023.12.006. Epub 2024 May 29. Arch Pediatr. 2024. PMID: 38811264
-
Immunoglobulin isotype-specific antibody responses to pneumococcal polysaccharide vaccine in patients with recurrent bacterial respiratory tract infections.Pediatr Res. 1995 Jun;37(6):812-9. doi: 10.1203/00006450-199506000-00023. Pediatr Res. 1995. PMID: 7651768
-
Overview of antibody-mediated immunity to S. pneumoniae: pneumococcal infections, pneumococcal immunity assessment, and recommendations for IG product evaluation.Transfusion. 2018 Dec;58 Suppl 3:3106-3113. doi: 10.1111/trf.15044. Transfusion. 2018. PMID: 30536434 Review.
Cited by
-
The natural history of ataxia-telangiectasia (A-T): A systematic review.PLoS One. 2022 Mar 15;17(3):e0264177. doi: 10.1371/journal.pone.0264177. eCollection 2022. PLoS One. 2022. PMID: 35290391 Free PMC article.
-
The genetic basis of pneumococcal and staphylococcal infections: inborn errors of human TLR and IL-1R immunity.Hum Genet. 2020 Jun;139(6-7):981-991. doi: 10.1007/s00439-020-02111-z. Epub 2020 Jan 24. Hum Genet. 2020. PMID: 31980906 Free PMC article. Review.
-
Altered mucosal immune response after acute lung injury in a murine model of Ataxia Telangiectasia.BMC Pulm Med. 2014 May 29;14:93. doi: 10.1186/1471-2466-14-93. BMC Pulm Med. 2014. PMID: 24884546 Free PMC article.
-
Pneumococcal conjugate vaccine followed by pneumococcal polysaccharide vaccine; immunogenicity in patients with ataxia-telangiectasia.Clin Exp Immunol. 2005 Jun;140(3):507-16. doi: 10.1111/j.1365-2249.2005.02791.x. Clin Exp Immunol. 2005. PMID: 15932512 Free PMC article.
-
Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-Telangiectasia.J Clin Immunol. 2021 Nov;41(8):1878-1892. doi: 10.1007/s10875-021-01090-8. Epub 2021 Sep 3. J Clin Immunol. 2021. PMID: 34477998 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous